PLATELET-ACTIVATING-FACTOR (PAF) - IMPLICATIONS FOR CORONARY HEART AND VASCULAR DISEASES

被引：93
作者：
EVANGELOU, AM
机构：
来源：
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1994年 / 50卷 / 01期
关键词：
D O I：
10.1016/0952-3278(94)90101-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：1 / 28
页数：28
相关论文
共 365 条
[11]   ACCUMULATION OF INFLAMMATORY CELLS IN RESPONSE TO INTRACUTANEOUS PLATELET ACTIVATING FACTOR (PAF-ACETHER) IN MAN [J].
ARCHER, CB ;
PAGE, CP ;
MORLEY, J ;
MACDONALD, DM .
BRITISH JOURNAL OF DERMATOLOGY, 1985, 112 (03) :285-290
[12]   MARKED INCREASE OF HUMAN-PLATELET PHOSPHOLIPASE-A2 ACTIVITY INVITRO AND DEMONSTRATION OF AN ENDOGENOUS INHIBITOR [J].
BALLOU, LR ;
CHEUNG, WY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (17) :5203-5207
[13]   INHIBITION OF HUMAN-PLATELET PHOSPHOLIPASE-A2 ACTIVITY BY UNSATURATED FATTY-ACIDS [J].
BALLOU, LR ;
CHEUNG, WY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (02) :371-375
[14]   THE EFFECTS OF PAF-ACETHER ON THE CARDIOVASCULAR-SYSTEM AND THEIR INHIBITION BY A NEW HIGHLY SPECIFIC PAF-ACETHER RECEPTOR ANTAGONIST BN 52021 [J].
BARANES, J ;
HELLEGOUARCH, A ;
LEHEGARAT, M ;
VIOSSAT, I ;
AUGUET, M ;
CHABRIER, PE ;
BRAQUET, P ;
BRAQUET, F .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1986, 18 (08) :717-737
[15]  
BARBARO JF, 1966, P SOC EXP BIOL MED, V122, P1245
[16]  
Barradas M A, 1992, In Vivo, V6, P629
[17]  
BARRETT M L, 1987, British Journal of Pharmacology, V90, p113P
[18]  
BARRETT M L, 1986, British Journal of Pharmacology, V89, p505P
[19]   PLATELET-DERIVED GROWTH-FACTOR GENE-EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES AND NORMAL ARTERY WALL [J].
BARRETT, TB ;
BENDITT, EP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2810-2814
[20]  
BARTHELSON R, 1988, FASEB J, V2, pA1228
12345678910